Articles with "immuno chemotherapy" as a keyword



Photo by nci from unsplash

DIRECT‐ACTING ANTIVIRALS DURING OR AFTER IMMUNO‐CHEMOTHERAPY IN HEPATITIS C VIRUS‐ASSOCIATED DIFFUSE LARGE B‐CELL LYMPHOMAS

Sign Up to like & get
recommendations!
Published in 2017 at "Hematological Oncology"

DOI: 10.1002/hon.2438_57

Abstract: vs 10.7%, p = 0.18) GVHD were also comparable as well as 2‐year GVHD free/relapse‐free survival (FB2: 44.4% vs 42.8%, p = 0.38). In multivariate analysis, there was a trend for worse outcome using FB3/FB4… read more here.

Keywords: chemotherapy hepatitis; direct acting; antivirals immuno; hepatitis virus ... See more keywords
Photo from wikipedia

Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection.

Sign Up to like & get
recommendations!
Published in 2021 at "International immunopharmacology"

DOI: 10.1016/j.intimp.2021.107606

Abstract: Patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) have a poor prognosis. This study investigated the efficacy of rituximab-containing immuno-chemotherapy regimens for EBV-HLH. In this study, 15 patients were treated with rituximab-containing regimens. The treatment efficacy… read more here.

Keywords: ebv hlh; containing immuno; immuno chemotherapy; rituximab containing ... See more keywords
Photo from wikipedia

A Two-way Cruise Nanosatellite Promotes Metastasis Inhibition by Immuno-chemotherapy.

Sign Up to like & get
recommendations!
Published in 2019 at "Biomacromolecules"

DOI: 10.1021/acs.biomac.9b00788

Abstract: Currently, immuno-chemotherapy based on tumor-associated macrophages (TAMs) is mainly used for elimination of M2 macrophages. However, these methods cannot make full use of the positive immune-modulatory effects of macrophages. This study explores a two-way cruise… read more here.

Keywords: chemotherapy; two way; way cruise; immuno chemotherapy ... See more keywords
Photo from wikipedia

Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma

Sign Up to like & get
recommendations!
Published in 2020 at "European Journal of Haematology"

DOI: 10.1111/ejh.13486

Abstract: Current UK standard of care in frontline advanced stage (III or IV) symptomatic follicular lymphoma (FL) is immuno-chemotherapy with anti-CD20 monoclonal antibodies (mAbs) rituximab (R) or obinutuzumab (O), in combination with cyclophosphamide, vincristine and prednisolone… read more here.

Keywords: efficacy infection; immuno chemotherapy; follicular lymphoma;
Photo by nci from unsplash

Iconic: Peri-operative immuno-chemotherapy in operable oesophageal and gastric cancer.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.15_suppl.tps4139

Abstract: TPS4139Background: Peri-operative chemotherapy with 5FU, oxaliplatin and docetaxel (FLOT) is a new standard of care in resectable gastro-oesophageal adenocarcinoma (GOA), however with 3y survival r... read more here.

Keywords: peri operative; iconic peri; peri; operative immuno ... See more keywords
Photo from wikipedia

First-line Immuno-chemotherapy for extensive-stage small-cell lung cancer: A network meta-analysis and cost-effectiveness analysis

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Public Health"

DOI: 10.3389/fpubh.2023.1028202

Abstract: Introduction Many randomized controlled trials have indicated that immuno-chemotherapy could generate clinical benefits, though the cost of immuno-chemotherapy was so prohibitive and the options were varied. This investigation aimed at evaluating effectiveness, safety, and cost-effectiveness… read more here.

Keywords: plus chemotherapy; cost; first line; analysis ... See more keywords
Photo from wikipedia

Neoadjuvant Immuno-Chemotherapy: A New Perspective for Stage III NSCLC?

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Surgery"

DOI: 10.3389/fsurg.2022.843987

Abstract: Background Stage III Non-small cell lung cancer (NSCLC) is a heterogenous disease with novel treatment options. Recently, immunotherapy has attracted a lot of attention for advanced NSCLC. Objective The objective of our study was to… read more here.

Keywords: stage iii; immuno chemotherapy; neoadjuvant immuno; stage ... See more keywords
Photo from wikipedia

The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review

Sign Up to like & get
recommendations!
Published in 2023 at "Cancers"

DOI: 10.3390/cancers15092476

Abstract: Simple Summary Surgical resections remain the gold standard for early stages non-small-cell carcinoma (NSCLC) and may be considered for locally advanced tumors. Medical treatment has changed drastically in recent years, especially for advanced stages, for… read more here.

Keywords: non small; immunotherapy; small cell; immuno chemotherapy ... See more keywords
Photo from wikipedia

HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Personalized Medicine"

DOI: 10.3390/jpm12020285

Abstract: Hepatitis B virus reactivation (HBVr) can develop in HBV surface antigen (HBsAg) positive or HBsAg-negative and anti-hepatitis B core antigen antibodies (anti-HBc) positive (past HBV infection) patients receiving immuno-chemotherapy for hematological malignancies. A higher rate… read more here.

Keywords: chemotherapy; immuno chemotherapy; non hodgkin; infection ... See more keywords